FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc. This action authorizes changes to the product under a suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)